{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:11:53Z","timestamp":1791288713514,"version":"4.3.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T00:00:00Z","timestamp":1434326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T00:00:00Z","timestamp":1434326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/bmt.2015.137","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T14:15:27Z","timestamp":1434377727000},"page":"1241-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia"],"prefix":"10.1038","volume":"50","author":[{"given":"S","family":"Kurosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Emi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Nakaseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,15]]},"reference":[{"key":"BFbmt2015137_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091\u20132101.","journal-title":"N Engl J Med"},{"key":"BFbmt2015137_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1200\/JCO.2010.32.5001","volume":"29","author":"JT Horan","year":"2011","unstructured":"Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK et al. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol 2011; 29: 805\u2013813.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/bmt.2013.42","volume":"48","author":"S Kurosawa","year":"2013","unstructured":"Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H et al. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplant 2013; 48: 1198\u20131204.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/bmt.2012.172","volume":"48","author":"S Kurosawa","year":"2013","unstructured":"Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H et al. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia\/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone Marrow Transplant 2013; 48: 529\u2013536.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12185-012-1150-6","volume":"96","author":"S Miyawaki","year":"2012","unstructured":"Miyawaki S . Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group. Int J Hematol 2012; 96: 171\u2013177.","journal-title":"Int J Hematol"},{"key":"BFbmt2015137_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/sj.leu.2402526","volume":"16","author":"J Takeuchi","year":"2002","unstructured":"Takeuchi J, Kyo T, Naito K, Sao H, Takahashi M, Miyawaki S et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia 2002; 16: 1259\u20131266.","journal-title":"Leukemia"},{"key":"BFbmt2015137_CR7","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1182\/blood-2004-04-1389","volume":"104","author":"M Towatari","year":"2004","unstructured":"Towatari M, Yanada M, Usui N, Takeuchi J, Sugiura I, Takeuchi M et al. Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood 2004; 104: 3507\u20133512.","journal-title":"Blood"},{"key":"BFbmt2015137_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","volume":"361","author":"B Lowenberg","year":"2009","unstructured":"Lowenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009; 361: 1235\u20131248.","journal-title":"N Engl J Med"},{"key":"BFbmt2015137_CR9","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","volume":"110","author":"S Bhatia","year":"2007","unstructured":"Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784\u20133792.","journal-title":"Blood"},{"key":"BFbmt2015137_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","volume":"28","author":"PJ Martin","year":"2010","unstructured":"Martin PJ, Counts GW Jr., Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011\u20131016.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","volume":"29","author":"JR Wingard","year":"2011","unstructured":"Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29: 2230\u20132239.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1046\/j.1365-2141.2000.02053.x","volume":"110","author":"S Chiodi","year":"2000","unstructured":"Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614\u2013619.","journal-title":"Br J Haematol"},{"key":"BFbmt2015137_CR13","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","volume":"108","author":"CJ Fraser","year":"2006","unstructured":"Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006; 108: 2867\u20132873.","journal-title":"Blood"},{"key":"BFbmt2015137_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bmt.1705434","volume":"38","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Kim HT, Ho VT, Cutler C, Alyea EP, Soiffer RJ et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 2006; 38: 305\u2013310.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","volume":"114","author":"J Pidala","year":"2009","unstructured":"Pidala J, Anasetti C, Jim H . Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009; 114: 7\u201319.","journal-title":"Blood"},{"key":"BFbmt2015137_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2141.2009.07992.x","volume":"148","author":"J Pidala","year":"2010","unstructured":"Pidala J, Anasetti C, Jim H . Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol 2010; 148: 373\u2013385.","journal-title":"Br J Haematol"},{"key":"BFbmt2015137_CR17","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","volume":"117","author":"J Pidala","year":"2011","unstructured":"Pidala J, Kurland B, Chai X, Majhail N, Weisdorf DJ, Pavletic S et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011; 117: 4651\u20134657.","journal-title":"Blood"},{"key":"BFbmt2015137_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbmt.2011.05.022","volume":"18","author":"V Gupta","year":"2012","unstructured":"Gupta V, Panzarella T, Li L, Khan J, Sharma A, Lipton JH et al. A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. Biol Blood Marrow Transplant 2012; 18: 113\u2013124.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015137_CR19","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1200\/JCO.2002.06.077","volume":"20","author":"TL Kiss","year":"2002","unstructured":"Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA . Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002; 20: 2334\u20132343.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR20","first-page":"319","volume":"11","author":"KL Syrjala","year":"1993","unstructured":"Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM . Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319\u2013327.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1200\/JCO.1999.17.2.706","volume":"17","author":"MJ Hjermstad","year":"1999","unstructured":"Hjermstad MJ, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S . Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 1999; 17: 706\u2013718.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.bmt.1704561","volume":"34","author":"MJ Hjermstad","year":"2004","unstructured":"Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 2004; 34: 257\u2013266.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR23","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/sj.bmt.1702046","volume":"24","author":"MJ Hjermstad","year":"1999","unstructured":"Hjermstad MJ, Loge JH, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S . The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219\u20131228.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3324\/haematol.11987","volume":"93","author":"D Messerer","year":"2008","unstructured":"Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008; 93: 826\u2013833.","journal-title":"Haematologica"},{"key":"BFbmt2015137_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0959-8049(03)00628-2","volume":"40","author":"M Watson","year":"2004","unstructured":"Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JK et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004; 40: 971\u2013978.","journal-title":"Eur J Cancer"},{"key":"BFbmt2015137_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0033-3182(96)71581-5","volume":"37","author":"DK Wellisch","year":"1996","unstructured":"Wellisch DK, Centeno J, Guzman J, Belin T, Schiller GJ . Bone marrow transplantation vs. high-dose cytorabine-based consolidation chemotherapy for acute myelogenous leukemia. A long-term follow-up study of quality-of-life measures of survivors. Psychosomatics 1996; 37: 144\u2013154.","journal-title":"Psychosomatics"},{"key":"BFbmt2015137_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.bmt.1700888","volume":"20","author":"R Zittoun","year":"1997","unstructured":"Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997; 20: 307\u2013315.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","volume":"104","author":"CS Cutler","year":"2004","unstructured":"Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004; 104: 579\u2013585.","journal-title":"Blood"},{"key":"BFbmt2015137_CR29","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1200\/JCO.2012.46.8652","volume":"31","author":"J Koreth","year":"2013","unstructured":"Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L et al. Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis. J Clin Oncol 2013; 31: 2662\u20132670.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.7326\/0003-4819-127-12-199712150-00005","volume":"127","author":"SJ Lee","year":"1997","unstructured":"Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA et al. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Ann Intern Med 1997; 127: 1080\u20131088.","journal-title":"Ann Intern Med"},{"key":"BFbmt2015137_CR31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","volume":"15","author":"J Pidala","year":"2009","unstructured":"Pidala J, Anasetti C, Kharfan-Dabaja MA, Cutler C, Sheldon A, Djulbegovic B . Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15: 1415\u20131421.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015137_CR32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1182\/blood-2010-05-285502","volume":"117","author":"S Kurosawa","year":"2011","unstructured":"Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Kanamori H, Usuki K et al. A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission. Blood 2011; 117: 2113\u20132120.","journal-title":"Blood"},{"key":"BFbmt2015137_CR33","volume-title":"Manual of SF-36v2 Japanese Version","author":"SSY Fukuhara","year":"2004","unstructured":"Fukuhara S SY . Manual of SF-36v2 Japanese Version. Institute for Health Outcomes & Process Evaluation Research: : Kyoto, 2004."},{"key":"BFbmt2015137_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","volume":"51","author":"S Fukuhara","year":"1998","unstructured":"Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K . Translation adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51: 1037\u20131044.","journal-title":"J Clin Epidemiol"},{"key":"BFbmt2015137_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jclinepi.2010.04.017","volume":"64","author":"Y Suzukamo","year":"2011","unstructured":"Suzukamo Y, Fukuhara S, Green J, Kosinski M, Gandek B, Ware JE . Validation testing of a three-component model of Short Form-36 scores. J Clin Epidemiol 2011; 64: 301\u2013308.","journal-title":"J Clin Epidemiol"},{"key":"BFbmt2015137_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jval.2012.08.2210","volume":"15","author":"D Cella","year":"2012","unstructured":"Cella D, Jensen SE, Webster K, Hongyan D, Lai JS, Rosen S et al. Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy\u2014Leukemia (FACT-Leu) questionnaire. Value Health 2012; 15: 1051\u20131058.","journal-title":"Value Health"},{"key":"BFbmt2015137_CR37","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","volume":"15","author":"MJ Brady","year":"1997","unstructured":"Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 1997; 15: 974\u2013986.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF00434949","volume":"1","author":"NK Aaronson","year":"1992","unstructured":"Aaronson NK, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992; 1: 349\u2013351.","journal-title":"Qual Life Res"},{"key":"BFbmt2015137_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337\u2013343.","journal-title":"Ann Med"},{"key":"BFbmt2015137_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jclinepi.2009.01.024","volume":"63","author":"D Turner","year":"2010","unstructured":"Turner D, Schunemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol 2010; 63: 28\u201336.","journal-title":"J Clin Epidemiol"},{"key":"BFbmt2015137_CR41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1200\/JCO.2001.19.1.242","volume":"19","author":"SJ Lee","year":"2001","unstructured":"Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol 2001; 19: 242\u2013252.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bmt.1701115","volume":"21","author":"RP McQuellon","year":"1998","unstructured":"McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ et al. Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant 1998; 21: 477\u2013486.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bmt.1705406","volume":"38","author":"MF Bevans","year":"2006","unstructured":"Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P et al. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 101\u2013109.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-3999(99)00059-8","volume":"48","author":"S Broers","year":"2000","unstructured":"Broers S, Kaptein AA, Le Cessie S, Fibbe W, Hengeveld MW . Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. J Psychosom Res 2000; 48: 11\u201321.","journal-title":"J Psychosom Res"},{"key":"BFbmt2015137_CR45","first-page":"1133","volume":"17","author":"JM Prieto","year":"1996","unstructured":"Prieto JM, Saez R, Carreras E, Atala J, Sierra J, Rovira M et al. Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1133\u20131142.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.bmt.1703677","volume":"30","author":"N Worel","year":"2002","unstructured":"Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619\u2013626.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR47","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/sj.bmt.1704646","volume":"34","author":"M Diez-Campelo","year":"2004","unstructured":"Diez-Campelo M, Perez-Simon JA, Gonzalez-Porras JR, Garcia-Cecilia JM, Salinero M, Caballero MD et al. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 2004; 34: 729\u2013738.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015137_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1034\/j.1600-0609.2000.90143.x","volume":"65","author":"M Kopp","year":"2000","unstructured":"Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 2000; 65: 97\u2013103.","journal-title":"Eur J Haematol"},{"key":"BFbmt2015137_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.2005.03.189","volume":"23","author":"MA Andrykowski","year":"2005","unstructured":"Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599\u2013608.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015137_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.NCC.0000265002.79687.af","volume":"30","author":"DK Tierney","year":"2007","unstructured":"Tierney DK, Facione N, Padilla G, Dodd M . Response shift: a theoretical exploration of quality of life following hematopoietic cell transplantation. Cancer Nurs 2007; 30: 125\u2013138.","journal-title":"Cancer Nurs"},{"key":"BFbmt2015137_CR51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cncr.11098","volume":"97","author":"L Sung","year":"2003","unstructured":"Sung L, Buckstein R, Doyle JJ, Crump M, Detsky AS . Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysis. Cancer 2003; 97: 592\u2013600.","journal-title":"Cancer"},{"key":"BFbmt2015137_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/bjc.1988.20","volume":"57","author":"ML Slevin","year":"1988","unstructured":"Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM . Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57: 109\u2013112.","journal-title":"Br J Cancer"},{"key":"BFbmt2015137_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/sj.bmt.1703158","volume":"28","author":"H Heinonen","year":"2001","unstructured":"Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant 2001; 28: 503\u2013509.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015137","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:15:31Z","timestamp":1648059331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,15]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFbmt2015137"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.137","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,15]]},"assertion":[{"value":"6 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}